Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

Should the U.S. consider marijuana a lower-risk drug?

Published

on

The U.S. Department of Health and Human Services (HHS) has proposed a relaxation of restrictions on marijuana, marking a significant step following a review request from the Biden Administration last year.

As the trend toward legalisation gains momentum across nearly 40 U.S. states, the move could signal a pivotal shift in marijuana’s legal status both at state and federal levels.

While marijuana has been legalised for various forms of use in almost 40 U.S. states, it remains prohibited in certain states and under federal law.

The HHS’s recommendation to reclassify marijuana reflects a push to acknowledge its potential benefits while demoting its perceived risks, in alignment with a growing majority of Americans who support broader legalisation.

The HHS conveyed its scheduling recommendation to the Drug Enforcement Agency (DEA) on Tuesday, as per President Biden’s directive.

The DEA, tasked with enforcing drug-related laws, possesses the authority to schedule or reschedule drugs under the Controlled Substances Act.

Presently designated as a schedule I drug, on par with heroin and LSD, marijuana’s classification implies high potential for abuse and lacks accepted medical applications.

The HHS’s proposal, in contrast, suggests a reclassification of marijuana to acknowledge its moderate to low potential for dependence and reduced abuse likelihood, likening it to substances such as ketamine and testosterone.

Should federal regulations around marijuana become more lenient, it could open doors for cannabis-related businesses. Major stock exchanges might allow the listing of such enterprises, and international companies could potentially enter the U.S. market.

White House Press Secretary Karine Jean-Pierre emphasised that the administration’s process is rooted in evidence and led by independent bodies such as HHS and the Department of Justice.

North of the border, cannabis has gained legal status in Canada, creating a haven for publicly traded cannabis businesses. Many of these Canadian entities are poised to expand into the U.S. market if federal legalisation progresses.

News of the proposed shift triggered a surge in the stock prices of various cannabis companies. Notable firms like Canopy Growth, Tilray Brands, and Cronos Group experienced stock price increases, while entities such as Verano Holdings and Sunburn Cannabis expressed support for the HHS’s move.

George Archos, CEO of Verano Holdings, articulated the sentiment shared among advocates for marijuana reform, citing the outdated scheduling status of cannabis as a hindrance and emphasising the harm caused by the historical “War on Drugs.”

The HHS’s recommendation marks a notable development in the ongoing dialogue surrounding marijuana’s legal status in the United States, potentially setting the stage for a broader reconsideration of its classification and the resulting implications.

Continue Reading

News

UnitedHealthcare CEO shot in targeted Manhattan attack

**UnitedHealthcare CEO Brian Thompson shot dead in targeted Manhattan attack; police investigating motive and suspect remains at large.**

Published

on

Brian Thompson, CEO of UnitedHealthcare’s insurance unit, was shot and killed outside a Hilton hotel in Midtown Manhattan.

The attack, described by police as targeted, occurred around 6:45 a.m. ET as Thompson was arriving for a company investor conference. Despite being rushed to a hospital, he was pronounced dead shortly after.

Authorities believe the shooter, who wore a mask and carried a gray backpack, had been lying in wait for Thompson. The suspect fled on foot before escaping on an electric bike.

Not random

New York City Police Commissioner Jessica Tisch indicated that this incident was not random but premeditated. The motive is still under investigation.

Thompson’s wife, Paulette, reported he had previously received threats. UnitedHealth, the largest U.S. health insurer, is facing scrutiny after a significant data breach earlier this year affecting healthcare services.

Witnesses noted the gunman targeted Thompson specifically, as he ignored other pedestrians. Local police confirmed Thompson was shot in the back and the suspect continued firing despite a malfunction in the weapon.

In light of the incident, UnitedHealthcare canceled the remainder of its investor conference and expressed condolences to Thompson’s family.

Continue Reading

News

French government collapses after no-confidence vote

French government collapses after National Assembly’s no-confidence vote, marking first such ousting in over 50 years.

Published

on

The French government led by President Emmanuel Macron fell after a no-confidence vote in the National Assembly.

This marks the first removal of a prime minister by lawmakers in over fifty years, highlighting significant political gridlock in the country.

The vote has left France’s public finances uncertain, as the country grapples with increasing political fragmentation.

Macron attempted to tackle the rise of Marine Le Pen and her far-right National Rally by calling for snap elections, which resulted in a hung parliament.

Budgetary measures

The Assembly is now divided among Macron’s supporters, Le Pen’s party, and a coalition of leftist groups, complicating efforts to approve essential budgetary measures for 2025.

Le Pen, alongside leftist lawmakers, supported the no-confidence motion after proposed spending cuts and tax hikes aimed at reducing a projected deficit exceeding 6% of GDP.

French President Macron.

Prime Minister Barnier stressed the need for urgent financial reforms, noting France’s debt servicing surpasses its defense budget. With limited options, Macron faces challenges in resolving the deadlock, as he cannot dissolve the Assembly and call for new elections until July.

He might appoint a new prime minister to push for a budget extension.

Le Pen expressed her willingness to support a budget extension while criticizing Barnier’s economic plans as harmful to working and middle-class citizens amidst a cost-of-living crisis.

Barnier’s recent fall from power has intensified calls for Macron’s resignation by opposition members, signaling a deepening crisis in French governance.

Continue Reading

News

Global leaders look to shape tech futures

Published

on

From disputed pay packages to tariff threats, global leaders are making waves in tech, trade, and innovation.

A U.S. judge has once again denied Elon Musk’s controversial $56 billion Tesla pay package, raising questions about the company’s governance practices. Meanwhile, Donald Trump’s tariff threats against BRICS nations could derail de-dollarization efforts, adding tension to global trade dynamics.

Concerns are also growing around Super Micro Computer audits, which have sparked fears of potential vulnerabilities in the tech sector. Additionally, Intel CEO Pat Gelsinger has announced his departure, leaving questions about whether his efforts to revitalise the company met expectations.

These developments underline the influence of leadership on shaping the global tech landscape, as decisions continue to ripple across industries.

Continue Reading

Trending Now